Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors

OBJECTIVE: Automated insulin delivery is the new standard for type 1 diabetes, but exercise-related hypoglycemia remains a challenge. Our aim was to determine whether a dual-hormone closed-loop system using wearable sensors to detect exercise and adjust dosing to reduce exercise-related hypoglycemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Castle, Jessica R., El Youssef, Joseph, Wilson, Leah M., Reddy, Ravi, Resalat, Navid, Branigan, Deborah, Ramsey, Katrina, Leitschuh, Joseph, Rajhbeharrysingh, Uma, Senf, Brian, Sugerman, Samuel M., Gabo, Virginia, Jacobs, Peter G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Emerging Therapies: Drugs and Regimens
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014543/
https://www.ncbi.nlm.nih.gov/pubmed/29752345
http://dx.doi.org/10.2337/dc18-0228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014543/
https://www.ncbi.nlm.nih.gov/pubmed/29752345
http://dx.doi.org/10.2337/dc18-0228

Ejemplares similares